Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 02-Apr-24 4:17 PM View:  | Saha Saurabh Chief Executive Officer Director | Centessa Pharmaceuticals Plc (CNTA) | 31-Mar-24 | Payment of Exercise | 36,263 | $11.30 | $409,772.00 | (4%) 942.45K to 906.19K | |
| 02-Apr-24 4:18 PM View: | Weinhoff Gregory M Chief Financial Officer | Centessa Pharmaceuticals Plc (CNTA) | 31-Mar-24 | Payment of Exercise | 11,742 | $11.30 | $132,685.00 | (4%) 276.85K to 265.11K | |
| 02-Apr-24 4:16 PM View: | Hussain Iqbal J General Counsel | Centessa Pharmaceuticals Plc (CNTA) | 31-Mar-24 | Payment of Exercise | 7,520 | $11.30 | $84,976.00 | (3%) 225.55K to 218.03K | |
| 02-Apr-24 4:19 PM View: | Chao David M Chief Administrative Officer | Centessa Pharmaceuticals Plc (CNTA) | 31-Mar-24 | Payment of Exercise | 10,385 | $11.30 | $117,350.00 | (4%) 283.37K to 272.99K | |
| 02-Apr-24 4:15 PM View: | Bush Tia L Chief Technology & Quality Ofc | Centessa Pharmaceuticals Plc (CNTA) | 31-Mar-24 | Payment of Exercise | 6,419 | $11.30 | $72,534.70 | (4%) 176.48K to 170.06K | |
| 26-Mar-24 4:16 PM View: | Anderson Karen M. Chief People Officer | Centessa Pharmaceuticals Plc (CNTA) | 25-Mar-24 | Option Exercise | 45,000 | $3.94 | $177,252.00 | 58% 77.69K to 122.69K | |
| 26-Mar-24 4:16 PM View: | Anderson Karen M. Chief People Officer | Centessa Pharmaceuticals Plc (CNTA) | 25-Mar-24 | Planned Option Sale | 45,000 | $11.88 | $534,758.00 | (37%) 122.69K to 77.69K | |
| 26-Mar-24 4:16 PM View: | Anderson Karen M. Chief People Officer | Centessa Pharmaceuticals Plc (CNTA) | 25-Mar-24 | Sale (Planned) | 6,160 | $11.88 | $73,202.40 | (8%) 77.69K to 71.53K | |
| 02-Feb-24 5:10 PM View: | Chao David M Chief Administrative Officer | Centessa Pharmaceuticals Plc (CNTA) | 01-Feb-24 | Grant | 37,500 | -- | -- | 15% 255.37K to 292.87K | |
| 02-Feb-24 5:03 PM View: | Rotman Harris SVP Regulatory Affairs | Centessa Pharmaceuticals Plc (CNTA) | 01-Feb-24 | Payment of Exercise | 4,108 | $8.19 | $33,644.50 | (6%) 71.0K to 66.89K | |
| 02-Feb-24 5:04 PM View: | Bush Tia L Chief Quality Officer | Centessa Pharmaceuticals Plc (CNTA) | 01-Feb-24 | Payment of Exercise | 3,862 | $8.19 | $31,629.80 | (2%) 180.34K to 176.48K | |
| 02-Feb-24 5:07 PM View: | Saha Saurabh Chief Executive Officer Director | Centessa Pharmaceuticals Plc (CNTA) | 01-Feb-24 | Grant | 144,200 | -- | -- | 17% 824.57K to 968.77K | |
| 02-Feb-24 5:02 PM View: | Anderson Karen M. Chief People Officer | Centessa Pharmaceuticals Plc (CNTA) | 01-Feb-24 | Grant | 31,250 | -- | -- | 58% 53.7K to 84.95K | |
| 02-Feb-24 5:10 PM View: | Chao David M Chief Administrative Officer | Centessa Pharmaceuticals Plc (CNTA) | 01-Feb-24 | Payment of Exercise | 9,503 | $8.19 | $77,829.60 | (3%) 292.87K to 283.37K | |
| 02-Feb-24 5:03 PM View: | Rotman Harris SVP Regulatory Affairs | Centessa Pharmaceuticals Plc (CNTA) | 01-Feb-24 | Sale (Planned) | 4,267 | $8.10 | $34,574.20 | (6%) 66.89K to 62.63K | |
| 02-Feb-24 5:08 PM View: | Weinhoff Gregory M Chief Financial Officer | Centessa Pharmaceuticals Plc (CNTA) | 01-Feb-24 | Grant | 31,250 | -- | -- | 12% 257.1K to 288.35K | |
| 02-Feb-24 5:09 PM View: | Hussain Iqbal J General Counsel | Centessa Pharmaceuticals Plc (CNTA) | 01-Feb-24 | Grant | 42,500 | -- | -- | 22% 190.94K to 233.44K | |
| 02-Feb-24 5:07 PM View: | Saha Saurabh Chief Executive Officer Director | Centessa Pharmaceuticals Plc (CNTA) | 01-Feb-24 | Payment of Exercise | 26,323 | $8.19 | $215,585.00 | (3%) 968.77K to 942.45K | |
| 02-Feb-24 5:02 PM View: | Anderson Karen M. Chief People Officer | Centessa Pharmaceuticals Plc (CNTA) | 01-Feb-24 | Payment of Exercise | 7,265 | $8.19 | $59,500.30 | (9%) 84.95K to 77.69K | |
| 02-Feb-24 5:03 PM View: | Rotman Harris SVP Regulatory Affairs | Centessa Pharmaceuticals Plc (CNTA) | 01-Feb-24 | Grant | 37,500 | -- | -- | 112% 33.5K to 71.0K | |
| 02-Feb-24 5:08 PM View: | Weinhoff Gregory M Chief Financial Officer | Centessa Pharmaceuticals Plc (CNTA) | 01-Feb-24 | Payment of Exercise | 11,494 | $8.19 | $94,135.90 | (4%) 288.35K to 276.85K | |
| 02-Feb-24 5:09 PM View: | Hussain Iqbal J General Counsel | Centessa Pharmaceuticals Plc (CNTA) | 01-Feb-24 | Payment of Exercise | 7,885 | $8.19 | $64,578.10 | (3%) 233.44K to 225.55K | |
| 02-Feb-24 5:04 PM View: | Bush Tia L Chief Quality Officer | Centessa Pharmaceuticals Plc (CNTA) | 01-Feb-24 | Grant | 42,500 | -- | -- | 31% 137.84K to 180.34K | |
| 02-Jan-24 7:43 PM View: | Saha Saurabh Chief Executive Officer Director | Centessa Pharmaceuticals Plc (CNTA) | 31-Dec-23 | Payment of Exercise | 36,263 | $7.96 | $288,653.00 | (4%) 860.84K to 824.57K | (13%) |
| 02-Jan-24 7:41 PM View: | Grainger David J Chief Innovation Officer | Centessa Pharmaceuticals Plc (CNTA) | 31-Dec-23 | Payment of Exercise | 4,700 | $7.96 | $37,412.00 | (< 1%) 994.99K to 990.29K | (13%) |
| 02-Jan-24 7:45 PM View: | Weinhoff Gregory M Chief Financial Officer | Centessa Pharmaceuticals Plc (CNTA) | 31-Dec-23 | Payment of Exercise | 11,742 | $7.96 | $93,466.30 | (4%) 268.84K to 257.1K | (13%) |
| 02-Jan-24 7:44 PM View: | Hussain Iqbal J General Counsel | Centessa Pharmaceuticals Plc (CNTA) | 31-Dec-23 | Payment of Exercise | 7,520 | $7.96 | $59,859.20 | (4%) 198.46K to 190.94K | (13%) |
| 02-Jan-24 7:37 PM View: | Bush Tia L Chief Quality Officer | Centessa Pharmaceuticals Plc (CNTA) | 31-Dec-23 | Payment of Exercise | 6,419 | $7.96 | $51,095.20 | (4%) 144.26K to 137.84K | (13%) |
| 02-Jan-24 7:46 PM View: | Chao David M Chief Administrative Officer | Centessa Pharmaceuticals Plc (CNTA) | 31-Dec-23 | Payment of Exercise | 10,419 | $7.96 | $82,935.20 | (4%) 265.79K to 255.37K | (13%) |
| 03-Oct-23 4:51 PM View: | Chao David M Chief Administrative Officer | Centessa Pharmaceuticals Plc (CNTA) | 30-Sep-23 | Payment of Exercise | 10,419 | $6.47 | $67,410.90 | (4%) 276.21K to 265.79K | |
| 03-Oct-23 4:53 PM View: | Saha Saurabh Chief Executive Officer Director | Centessa Pharmaceuticals Plc (CNTA) | 30-Sep-23 | Payment of Exercise | 36,263 | $6.47 | $234,622.00 | (4%) 897.1K to 860.84K | |
| 03-Oct-23 4:59 PM View: | Grainger David J Chief Innovation Officer | Centessa Pharmaceuticals Plc (CNTA) | 30-Sep-23 | Payment of Exercise | 4,700 | $6.47 | $30,409.00 | (< 1%) 999.69K to 994.99K | |
| 03-Oct-23 4:56 PM View: | Weinhoff Gregory M Chief Financial Officer | Centessa Pharmaceuticals Plc (CNTA) | 30-Sep-23 | Payment of Exercise | 11,742 | $6.47 | $75,970.70 | (4%) 280.58K to 268.84K | |
| 03-Oct-23 10:00 PM View: | Hussain Iqbal J General Counsel | Centessa Pharmaceuticals Plc (CNTA) | 30-Sep-23 | Payment of Exercise | 7,520 | $6.47 | $48,654.40 | (4%) 205.97K to 198.46K | |
| 03-Oct-23 4:46 PM View: | Bush Tia L Chief Quality Officer | Centessa Pharmaceuticals Plc (CNTA) | 30-Sep-23 | Payment of Exercise | 6,419 | $6.47 | $41,530.90 | (4%) 150.68K to 144.26K | |
| 22-Sep-23 4:47 PM View: | Rotman Harris SVP Regulatory Affairs | Centessa Pharmaceuticals Plc (CNTA) | 20-Sep-23 | Option Exercise | 37,484 | $4.37 | $163,688.00 | 112% 33.5K to 70.98K | |
| 22-Sep-23 4:47 PM View: | Rotman Harris SVP Regulatory Affairs | Centessa Pharmaceuticals Plc (CNTA) | 20-Sep-23 | Planned Option Sale | 37,484 | $6.29 | $235,688.00 | (53%) 70.98K to 33.5K | |
| 03-Jul-23 5:35 PM View: | Chao David M Chief Administrative Officer | Centessa Pharmaceuticals Plc (CNTA) | 30-Jun-23 | Payment of Exercise | 10,419 | $5.90 | $61,473.10 | (4%) 286.63K to 276.21K | |
| 03-Jul-23 5:32 PM View: | Saha Saurabh Chief Executive Officer Director | Centessa Pharmaceuticals Plc (CNTA) | 30-Jun-23 | Payment of Exercise | 36,263 | $5.90 | $213,955.00 | (4%) 933.36K to 897.1K | |
| 03-Jul-23 5:31 PM View: | Grainger David J Chief Innovation Officer | Centessa Pharmaceuticals Plc (CNTA) | 30-Jun-23 | Payment of Exercise | 4,290 | $5.90 | $25,311.40 | (< 1%) 1.0M to 999.69K | |
| 03-Jul-23 5:33 PM View: | Weinhoff Gregory M Chief Financial Officer | Centessa Pharmaceuticals Plc (CNTA) | 30-Jun-23 | Payment of Exercise | 11,742 | $5.90 | $69,279.00 | (4%) 292.32K to 280.58K | |
| 03-Jul-23 5:34 PM View: | Hussain Iqbal J General Counsel | Centessa Pharmaceuticals Plc (CNTA) | 30-Jun-23 | Payment of Exercise | 7,104 | $5.90 | $41,914.30 | (3%) 213.08K to 205.97K | |
| 03-Jul-23 5:29 PM View: | Bush Tia L Chief Quality Officer | Centessa Pharmaceuticals Plc (CNTA) | 30-Jun-23 | Payment of Exercise | 6,419 | $5.90 | $37,872.70 | (4%) 157.1K to 150.68K | |
| 02-Jun-23 5:01 PM View: | Yver Antoine EVP & Chairman of Development | Centessa Pharmaceuticals Plc (CNTA) | 01-Jun-23 | Sale (Planned) | 6,500 | $4.45 | $28,949.10 | (< 1%) 789.57K to 783.07K | |
| 26-May-23 5:01 PM View: | Bush Tia L Chief Quality Officer | Centessa Pharmaceuticals Plc (CNTA) | 24-May-23 | Sale | 8,000 | $4.48 | $35,865.30 | (5%) 165.1K to 157.1K | |
| 02-May-23 10:00 PM View: | Yver Antoine EVP & Chairman of Development | Centessa Pharmaceuticals Plc (CNTA) | 01-May-23 | Sale (Planned) | 6,800 | $4.42 | $30,083.20 | (< 1%) 796.37K to 789.57K | |
| 04-Apr-23 5:03 PM View: | Yver Antoine EVP & Chairman of Development | Centessa Pharmaceuticals Plc (CNTA) | 03-Apr-23 | Sale (Planned) | 6,700 | $3.69 | $24,729.70 | (< 1%) 803.07K to 796.37K | |
| 04-Apr-23 5:05 PM View: | Chao David M Chief Administrative Officer | Centessa Pharmaceuticals Plc (CNTA) | 31-Mar-23 | Payment of Exercise | 6,969 | $3.90 | $27,179.10 | (2%) 293.6K to 286.63K | |
| 04-Apr-23 5:04 PM View: | Templeman Thomas Chief Technology Officer | Centessa Pharmaceuticals Plc (CNTA) | 31-Mar-23 | Payment of Exercise | 4,103 | $3.90 | $16,001.70 | (2%) 192.35K to 188.24K | |
| 04-Apr-23 5:02 PM View: | Grainger David J Chief Innovation Officer | Centessa Pharmaceuticals Plc (CNTA) | 31-Mar-23 | Payment of Exercise | 4,825 | $3.90 | $18,817.50 | (< 1%) 1.01M to 1.0M |
